Proprietary Pipeline Read more about our Proprietary Pipeline We have a broad portfolio of potential drug candidates in preclinical or clinical stages. Tesomet for treatment of Prader-Willi Syndrome and Hypothalamic Obesity See more SAN711 for the treatment of rare neuropathic disorders See more SAN903 for rare inflammatory and fibrotic disorders See more Next